Dr. Licht is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2033 Mowry Road
145
Gainesville, FL 32610Phone+1 352-273-8143Fax+1 352-273-7969
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1988
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1982 - 1985
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1982
Certifications & Licensure
- FL State Medical License 2016 - 2026
- NY State Medical License 1991 - 2018
- IL State Medical License 2006 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Elected Member The American Society for Clinical Investigation, 2001, 2007
Publications & Presentations
PubMed
- The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion gene...Andrea Berardi, Charlotte Leonie Kaestner, Michela Ghitti, Giacomo Quilici, Paolo Cocomazzi
Nucleic Acids Research. 2025-01-07 - 8 citationsRecruitment of FBXO22 for targeted degradation of NSD2.David Y Nie, John R Tabor, Jianping Li, Maria Kutera, Jonathan St-Germain
Nature Chemical Biology. 2024-12-01 - 1 citationsKDM6A regulates immune response genes in multiple myeloma.Daphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, Sayantan Maji, Heidi Casellas Román
Blood. 2024-10-03
Abstracts/Posters
- Systematic Characterization of Genes Representing Preferential Molecular Vulnerabilities for Myeloma Cells Compared to Other Neoplasias _ Implications for the Biology ...Jonathan D. Licht, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of OncoproteinsJonathan D. Licht, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- DNMT3A with Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksJonathan D. Licht, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Targeting Epigenetic Regulation in Myeloma60th American Society of Hematology Annual Meeting - 12/2/2018
- CRISPR-Based Functional Genomics Studies Reveal Distinct and Overlapping Genes Mediating Resistance to Different Classes of Heterobifunctional Degraders of Oncoprotein...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Functional Genomic Landscape of Genes with Recurrent Mutations in Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Correlation Between Asthma and Increased Cancer RiskMay 17th, 2023
- Do You Have Asthma? You May Be More Likely to Develop Certain CancersMay 3rd, 2023
- UF Study Links Asthma and Cancer RiskApril 13th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: